No icon

Passion IT Framework

Pfizer Announces Positive Results With Coadministration of Prevnar 20, COVID-19 Vaccine

Pfizer has announced positive topline results from a phase 3 study evaluating the safety and immunogenicity of the company’s pneumococcal 20-valent conjugate vaccine (Prevnar 20) when coadministered with the Pfizer-BioNTech COVID-19 vaccine.

Read More at:

https://www.pharmacytimes.com/view/pfizer-announces-positive-results-with-coadministration-of-prevnar-20-covid-19-vaccine

Comment